Alan Daugherty

Oct. 19: Cardiovascular research

Delaware Cardiovascular Research Center sets second annual symposium

TEXT SIZE

3:44 p.m., Sept. 6, 2012--The Delaware Cardiovascular Research Center (DCRC) will hold its second annual symposium from 8 a.m. to 5 p.m., Friday, Oct. 19, at the Embassy Suites Hotel, 654 South College Avenue, in Newark.

The symposium will bring together cardiovascular researchers from tri-state area institutions to share recent advances in the field and to facilitate productive collaborations through idea sharing and the development of an infrastructure for cardiovascular disease education and research. 

Research Stories

Pavilion Lake Project

A multi-disciplinary project funded by NASA and the Canadian Space Agency is aimed at studying exploration while examining unusual life forms.

Alum is innovator

A team of researchers at Michigan State University, which is led by University of Delaware alumnus Richard R. Lunt, has developed a new type of solar concentrator.

The morning keynote speaker is Alan Daugherty of the University of Kentucky (UK), who will speak about the role of angiotensin peptides in the development of atherosclerosis and aortic aneurysms. 

Daugherty is the director of the Cardiovascular Research Center at UK and is the editor-in-chief of Atherosclerosis, Thrombosis and Vascular Biology, the official journal of the American Heart Association. 

The afternoon session welcomes keynote speaker Tatiana Byzova, the Robert Canova Endowed Chair in Angiogenesis Research in the Department of Molecular Cardiology, Center for Thrombosis and Vascular Biology at the
Lerner Research Institute, Cleveland Clinic Foundation.

Byzova will speak about the mechanisms governing the pathological and adaptive vasculature development and neoangiogenesis in adult organisms. 

There will also be presentations by invited faculty from the University of Delaware, Temple University, the University of Pennsylvania, Thomas Jefferson University, and guest speakers from the National Institutes of Health Chemical Genomics Center (NCGC), Nemours, Merck Pharmaceuticals and Perkin Elmer.

Presentations will be on basic and translational cardiovascular research as well as molecular mechanism of thrombosis, anti-thrombotic interventions, and assay development for high throughput screening for intervention of various cardiovascular diseases.

In addition, there will be a poster session featuring work by UD scientists, graduate students, and outside presenters. Several awards for the outstanding posters will be presented. Posters should be no larger than 32 by 40 inches. Vendors will also be on-site.

The symposium is free and a continental breakfast and lunch will be provided, however registration is required. Registration is available on the DCRC website.

icon-fb icon-tw icon-yt icon-fs
ADVERTISEMENT

News Media Contact

University of Delaware
Office of Communications & Marketing
302-831-NEWS
ud-ocm@udel.edu

UDaily is produced by the
Office of Communications & Marketing

The Academy Building
105 East Main Street
University of Delaware
Newark, DE 19716 | USA
Phone: (302) 831-2792
email: ud-ocm@udel.edu
www.udel.edu/ocm
University of Delaware • Newark, DE 19716
ud-ocm@udel.edu • (302) 831-2792 • ©2012
University of Delaware • Newark, DE 19716 • USA • Phone: (302) 831-2792 • © 2013
Comments|Contact Us|Legal Notices